SERRAzyme (Serrapeptase)

SERRAzyme Clinical Study

SERRAzyme consists exclusively of serratiopeptidase, more commonly recognized as serrapeptase. Serrapeptase is a proteolytic enzyme initially identified within the intestinal environment of silkworms, derived through the isolation process involving the microorganism Serratia E-15.

When administered on an empty stomach, serrapeptase, an enzyme with fibrinolytic properties, is absorbed into the bloodstream through the small intestine. Serrapeptase initiates fibrinolysis within the body, leveraging its intrinsic protein-digesting capabilities to promote regular sinus function and facilitate a typical inflammatory response to excessive physical exertion.

SERRAzyme facilitates expedited recovery following sports-related injuries, surgical procedures, muscle strains and sprains, while also fostering optimal sinus functionality.

While SERRAzyme contains the exceptionally potent serrapeptase, it can be seamlessly integrated into your supplement regimen with a proven track record of safety. To date, no significant adverse events have been reported in association with the use of SERRAzyme. Nonetheless, it is imperative to adhere to the recommended dosage instructions, unless otherwise specified by your healthcare provider.

PBE has innovated an entirely natural, chemical-free acid-resistant capsule. These capsules are constructed with an enhanced layer of cellulose (vegetable capsules) and feature a micro-threaded locking mechanism to prevent any leakage. Our capsules have been meticulously engineered to endure the acidic conditions of the stomach, ensuring the contents are released and activated within the alkaline environment of the small intestine, where they can achieve systemic efficacy.

Optimal results are achieved when SERRAzyme is consumed at least one hour before a meal or two hours after eating.

SERRAzyme synergizes effectively with other supplements, offering a safe complement. We, in fact, recommend its concurrent use with PBE NATTO or PBE Protease to provide added support for fibrinolysis, anti-inflammatory response, and probiotic benefits.

While individual responses may vary, certain individuals have reported experiencing the effects of systemic enzymes within as little as 45 minutes. For therapeutic protocols, the pace of progress may vary, with some individuals experiencing gradual improvements and others noting quicker results.

Clinical research has demonstrated that serrapeptase can effectively reduce mucosal secretions and alleviate pain stemming from injuries. Typically, these effects become noticeable within days when using most other serrapeptase brands. However, SERRAzyme, formulated with therapeutically dosed serrapeptase, has shown a faster onset of efficacy across all relevant applications of serrapeptase.

The formulation aligns with the standards set forth by the AMERICAN VEGETARIAN ASSOCIATION, ensuring a vegetarian-friendly product.

SERRAzyme is certified as non-GMO. The microorganisms employed in the production of this enzyme product do not involve genetically engineered organisms, as per the definition provided by the NATIONAL ORGANIC STANDARDS BOARD. Genetic engineering encompasses methods that modify the molecular or cellular biology of an organism in ways that are unattainable through natural processes or conditions. This definition encompasses techniques such as recombinant DNA, cell fusion, micro- and macro-encapsulation, gene deletion and duplication, introduction of foreign genes, and altering gene positions. It explicitly excludes traditional breeding, conjugation, fermentation, hybridization, in-vitro fertilization, and tissue culture.